Invention Grant
- Patent Title: Compound for treating or preventing hyperuricemia or gout
-
Application No.: US15758866Application Date: 2016-09-08
-
Publication No.: US10399971B2Publication Date: 2019-09-03
- Inventor: Dongfang Shi , Changjin Fu , Xi Cheng , Jianghua Zhu , Jie Wen , Jie Gu
- Applicant: JIANGSU ATOM BIOSCIENCE AND PHARMACEUTICAL CO., LTD.
- Applicant Address: CN Zhenjiang
- Assignee: JIANGSU ATOM BIOSCIENCE AND PHARMACEUTICAL CO., LTD.
- Current Assignee: JIANGSU ATOM BIOSCIENCE AND PHARMACEUTICAL CO., LTD.
- Current Assignee Address: CN Zhenjiang
- Agency: CBM Patent Counsulting, LLC
- Priority: CN201510576110 20150910
- International Application: PCT/CN2016/098468 WO 20160908
- International Announcement: WO2017/041732 WO 20170316
- Main IPC: C07D471/04
- IPC: C07D471/04 ; A61K31/437 ; A61P19/06
Abstract:
The invention discloses a class of compounds for treating or preventing hyperuricemia or gout, which is a compound shown in general formula (I) or a pharmaceutically acceptable salt. These compounds and their pharmaceutically acceptable salts in the invention are useful for the promotion of uric acid excretion to treat or prevent hyperuricemia or gout.
Public/Granted literature
- US20180282321A1 COMPOUND FOR TREATING OR PREVENTING HYPERURICEMIA OR GOUT Public/Granted day:2018-10-04
Information query
